GWM
JUNO

Gupta Wealth Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Gupta Wealth Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$76K Hold
2,000
– – 0.02% 378
2015
Q4 		$88K Hold
2,000
– – 0.02% 341
2015
Q3 		$81K Buy
+2,000
New +$87.7K 0.02% 373

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Gupta Wealth Management's JUNO Position: Q1 2016 in Review

Gupta Wealth Management held its Juno Therapeutics, Inc. (JUNO) position steady in Q1 2016 at 2,000 shares worth $76K. The position accounts for 0.02% of the portfolio, ranked #378.

Gupta Wealth Management first reported a position in JUNO in Q3 2015 and has held it in 3 quarters since. The position peaked at $88K in Q4 2015. 158 funds tracked by Wall St. Rank hold JUNO as of Q1 2016.

  • Gupta Wealth Management held 2,000 shares of Juno Therapeutics, Inc. worth $76K as of Q1 2016.
  • Gupta Wealth Management left its Juno Therapeutics, Inc. share count unchanged in Q1 2016.
  • Juno Therapeutics, Inc. made up 0.02% of Gupta Wealth Management's portfolio in Q1 2016, its #378 holding.
  • Gupta Wealth Management first reported a position in Juno Therapeutics, Inc. in Q3 2015 and has held it in 3 quarters since.
  • Gupta Wealth Management's Juno Therapeutics, Inc. position peaked at $88K in Q4 2015.
  • 158 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.